Cited by 122Circadian rhythm and melatoninNeurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Fluoxetine Modulates the Circadian Biological Clock via Phase Advances of Suprachiasmatic Nucleus Neuronal Firing

Sprouse, Jeffrey, Braselton, John, Reynolds, Linda·2006·Biological Psychiatry

Abstract

Background The documented ability of serotonin (5-HT) to directly modulate circadian rhythms prompted interest in a similar role for therapeutic agents that readily enhance 5-HT neurotransmission, namely the selective serotonin reuptake inhibitors (SSRIs).Methods Extracellular recordings of unit firing of suprachiasmatic nucleus (SCN) neurons maintained in slice culture enabled determinations of circadian rhythmicity. Shifts in the peak of activity were determined during the next circadian cycle following drug exposure.Results Fluoxetine (10 microm, 60 minutes incubation) produced robust phase advances only in the presence of L-tryptophan (.5 microm), added to maintain serotonergic tone.Conclusions Actions of SSRIs at the level of the circadian biological clock add to the list of pharmacological effects for this drug class and encourage speculation as to their importance clinically.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2006.03.003

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Antidepressant and mood-stabilizing medications, such as lithium, valproic acid and SSRIs, all have dramatic effects on gene expression rhythms that may, at least in part, underlie their therapeutic efficacy.

    “antidepressant and mood-stabilizing medications, such as lithium, valproic acid and selective serotonin reuptake inhibitors (SSRIs), all have dramatic effects on gene expression rhythms that may, at least in part, underlie their therapeutic efficacy215–217”
  • Several first-line pharmacological treatments for psychiatric disorders, such as lithium for bipolar disorder and SSRIs for major depressive disorders, modulate the circadian clock.

    “Several first-line pharmacological treatments for psychiatric disorders, such as lithium for bipolar disorder and SSRIs for major depressive disorders, modulate the circadian clock216,217,329–331.”
  • Fluoxetine affects circadian output by producing a phase advance in the firing of SCN neurons in rat slice culture.

    “Similar to morning bright light therapy, the antidepressant, fluoxetine, also affects circadian output by producing a phase advance in the firing of SCN neurons in rat slice culture (Sprouse et al., 2006).”

    From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Sprouse et al., 2006

  • The opposing therapeutic actions of SSRIs and mood stabilizers in bipolar patients could be linked to their opposing actions on rhythms, since SSRIs cause a phase advance in rhythms while lithium can cause a phase delay.

    “This could be linked to their opposing actions on rhythms since SSRIs cause a phase advance in rhythms while lithium can cause a phase delay (Campbell et al., 1989; Sprouse et al., 2006).”

    From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Sprouse et al., 2006

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sprouse, J., Braselton, J., & Reynolds, L.
Affiliations
Pfizer (United States) (US)
Corresponding author
Sprouse, Jeffrey
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2006-10
Volume
60
Issue
8
Pages
896-899
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2068814879
Cited by
122
References
31
Citations by year
2026: 1 · 2025: 1 · 2024: 6 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 7 · 2019: 3 · 2018: 8 · 2017: 5 · 2016: 4 · 2015: 8 · 2014: 4 · 2013: 9 · 2012: 13
FWCI
3.22
Type
journal article
Language
en
Open access
closed
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
fluoxetine, circadian rhythm, suprachiasmatic nucleus, phase advance, selective serotonin reuptake inhibitors, serotonin, tryptophan, neuronal firing
MeSH terms
Animals, Circadian Rhythm, Electric Stimulation, Electrophysiology, Fluoxetine, Male, Neurons, Serotonin, Suprachiasmatic Nucleus, Tryptophan, Rats, Sprague-Dawley, Selective Serotonin Reuptake Inhibitors, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review